News for Xlife Sciences AG (XLS.MU)

Published at

Feb 17, 2021 6:47 AM

by marketscreener.com

mixed

mixed

Xlife Sciences AG (XLS): Antiviral drug candidate

DGAP-Ad-hoc: Xlife Sciences AG / Key word: Research Update Xlife Sciences AG : Antiviral drug candidate 17-Feb-2021 / 06:44 CET/CEST Disclosure of an inside information acc. to Article 17 MAR...

XLS.F XLS.DE XLS.MU KEY EQS.MU EQS.F EQS.DE

Read more →
Published at

Jan 8, 2021 9:09 AM

by marketscreener.com

positive

positive

Xlife Sciences AG: Transaction with Baliopharm AG

License Deal of 300 million euros successfully completed ...

XLS.MU XLS.F XLS.DE

Read more →
Published at

Jan 8, 2021 6:48 AM

by marketscreener.com

mixed

mixed

DGAP-Adhoc : Xlife Sciences AG: Transaction with Baliopharm AG

DGAP-Ad-hoc: Xlife Sciences AG / Key word: Contract Xlife Sciences AG: Transaction with Baliopharm AG 08-Jan-2021 / 06:47 CET/CEST Disclosure of an inside information acc. to Article 17 MAR...

XLS.MU XLS.F XLS.DE EQS.MU EQS.F EQS.DE FN

Read more →